Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for Financial Results of Q2 FY 2025-26.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories Limited has submitted to NSE a copy of the newspaper advertisement publishing its financial results for the second quarter of FY 2025-26. This is a routine regulatory compliance requirement under SEBI's listing regulations, where listed companies must publish their quarterly results in newspapers. No specific financial figures or details were disclosed in this filing, as it only confirms that the publication was carried out. Investors should refer to the company's earlier results filing or the newspaper notice itself for actual numbers like revenue, profit, or EPS.
No direct impact on shareholders or stock price, as this is a procedural compliance filing rather than new financial information. The actual Q2 results would have been filed separately earlier.